$97,500
median · per year, annualized USD
$103,325
median · per year, annualized USD
Sales Development Representative - Medical Equipment
Respiratory Pharmaceutical Sales Representative – Greater Baltimore, MD
Respiratory Pharmaceutical Sales Representative - Bel-Air, MD
Respiratory Pharmaceutical Sales Representative – Salisbury, MD
Sales Representative - Specialty Medical Products
Respiratory Pharmaceutical Sales Representative – Syracuse, NY
Medical Sales Representative (Iowa)
Pharmaceutical Sales Representative - GI - St. Louis, MO
Medical Sales Representative - Acute Care
Medical Sales Representative - Acute Care
Senior Patient Safety and Pharmacovigilance Operations Specialist II
Senior Specialist I, Postmarketing Patient Safety and Pharmacovigilance Operations
Senior Medical Officer-Infectious Diseases & Pharmacovigilance
Pharmacovigilance QA Auditor Specialist
Pharmacovigilance Specialist - US - Remote
Drug Safety Associate - Bilingual - French - 12-Month Contract
| Company | Median | Roles |
|---|---|---|
Inizio Engage
|
$85,500 | 53 |
| ME Medline | $125,000 | 7 |
GSK
|
$156,000 | 4 |
IQVIA
|
$107,500 | 4 |
Cardinal Health
|
$117,040 | 2 |
Danaher
|
$95,000 | 2 |
CHG Healthcare
|
$60,000 | 2 |
Huzzle
|
$563,495 | 1 |
| Company | Median | Roles |
|---|---|---|
Corcept Therapeutics
|
$160,425 | 2 |
| GU Guidehouse | $113,000 | 1 |
Johnson & Johnson
|
$103,325 | 1 |
| WC Worldwide Clinical Trials | $74,500 | 1 |
Cencora
|
$31,298 | 1 |
The median for Pharmaceutical Sales is $97,500 per year (typically $78,220–$131,000), versus $103,325 for Pharmacovigilance ($74,500–$113,000). That puts Pharmacovigilance about 6% ahead at the median.
Both figures are computed live from active listings on JobsRadar and normalized to annualized USD, so Pharmaceutical Sales and Pharmacovigilance are compared on equal terms regardless of the currency each role was originally posted in. Only roles that publish a salary range feed the medians; numbers refresh every few hours as new roles post and older ones close, so this comparison reflects the market right now rather than a fixed survey. Use it as a directional benchmark when weighing one path against the other.